Antibiotic susceptibility of staphylococci isolated in blood cultures in relation to antibiotic consumption in hospital wards

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 4, 1999, Pages 399-404

  Monsen, Tor ^a   Rönnmark, Marianne ^a   Olofsson, Carin ^a   Wiström, Johan ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; CLINDAMYCIN; COAGULASE; COTRIMOXAZOLE; FUSIDIC ACID; GENTAMICIN; OXACILLIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; COMPARATIVE STUDY; DISEASE CONTROL; DRUG UTILIZATION; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MICROCOCCACEAE; MULTIDRUG RESISTANCE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS; SWEDEN; UNIVERSITY HOSPITAL; WARD;

ANTI-BACTERIAL AGENTS; COAGULASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HOSPITAL DEPARTMENTS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; SWEDEN;

EID: 0344631678     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549950163860     Document Type: Article

References (21)

1. Kloos WE, Bannerman TL. Staphylococcus and micrococcus. In: Murray PR, Barron EJ, Pfaller MA, Tenover FC, Yolken RH, eds. Manual of clinical microbiology, 6th edn. Washington, DC: American Society for Microbiology, 1995: 282-98.
2. Kloos WE, Bannerman TL. Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994; 7: 117-40.
3. Rupp ME, Archer GL. Coagulase-negative skin staphylococci: pathogens associated with medical progress. Clin Infect Dis 1994; 19: 231-45.
4. Monsen T, Rönnmark M, Olofsson C, Wiström J. An inexpensive and reliable method for routine identification of Staphylococcal species. Eur J Clin Microbiol Infect Dis 1998; 17: 327-35.
5. Kloos WE, Schleifer KM. Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol 1975; 1: 82-8.
6. Jarløv JO, Højbjerg T, Busch-Sørenensen C, Schleibel J, Møller JK, Kolmos HJ, et al. Coagulase-negative staphylococci in Danish blood cultures: species distribution and antibiotic susceptibility. J Hosp Infect 1996; 32: 217-27.
7. de Neeling AJ, van Leeuwen WJ, Schouls LM, Schot CS, van Veen-Rulgers A, Beunders AJ, et al. Resistance of staphylococci in the Netherlands: surveillance by an electronic network during 1989-1995. J Antimicrob Chemother 1998; 41: 93-101.
8. Turano A, Ravizzola G, Peroni L, Ceruti T, Greco LM, Pitzus E, et al. A multicentre study: Staphylococcus and Enterococcus susceptibility to antibiotics. Eur J Epidemiol 1994; 10: 567-72.
9. Durand-Gasselin B, Leclercq R, Girard-Pipau F, Deharvegnt MC, Rochant H, Astier A, et al. Evolution of bacterial susceptibility to antibiotics during a six-year period in a haematology unit. J Hosp Infect 1995; 29: 19-33.
10. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Agents Chemother 1998; 42: 1762-70.
11. Jarlav JO, Høiby N. Coagulase-negative staphylococci in a major Danish university hospital: diversity in antibiotic susceptibility between wards. APMIS 1998; 106: 411-6.
12. Westh H, Thamdrup Rosdahl V, Friis H. Erythromycin resistance in Danish Staphylococcus aureus hospital strains with emphasis on erythromycin consumption. APMIS 1989; 97: 1121-4.
13. Mouton RP, Hermans J, Simoons-Smit AM, Hoogkamp-Korstanje JA, Degener JE, van Klingeren B. Correlations between consumption of antibiotics and methicillin resistance in coagulase negative staphylococci. J Antimicrob Chemother 1990; 26: 573-83.
14. Oppenheim BA, Hartley JW, Lee W, Burnie JP. Outbreak of coagulase-negative staphylococcus highly resistant to ciprofloxacin in a leukemia unit. Br Med J 1989; 299: 294-7.
15. Kotilainen P, Huovinen S, Jarvinen H, Aro H, Huovinen P. Epidemiology of the colonization of inpatients and outpatients with ciprofloxacin-resistant coagulase-negative staphylococci. Clin Infect Dis 1995; 21: 685-7.
16. Pegues DA, Colby C, Hibberd PL, Cohen LG, Ausubel FM, Calderwood SB, et al. The epidemiology of resistance to ofloxacin and oxacillin among clinical coagulase-negative staphylococcal isolates: analyses of risk factors and strain types. Clin Infect Dis 1998; 26: 72-9.
17. Kirchhoff LV, Sheagren JN. Epidemiology and clinical significance of blood cultures positive for coagulase-negative staphylococcus. Infect Control 1985; 6: 479-86.
18. Weinstein MP, Towns ML, Quartey SM, Reimer LG, Parmigiani G, Reller B. The clinical significance of blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis 1997; 24: 584-602.
19. Pfaller MA, Herwaldt LA. Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev 1988; 1: 281-99.
20. Sidebottom DG, Freeman J, Platt R, Epstein MF, Goldmann DA. Fifteen-year experience with blood stream isolates of coagulase-negative staphylococci in neonatal intensive care. J Clin Microbiol 1988; 26: 713-8.
21. Kacica MA, Horgan MJ, Preston KE, Lepow M, Venezia RA. Reletedness of coagulase-negative staphylococci causing bacteremia in low-birthweight infants. Infect Control Hosp Epidemiol 1994; 15: 658-62.